Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02942121 · ClinicalTrials.gov registry record · NA
Application-based Perioperative Management of the Radical Cystectomy Patient
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02942121 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT02942121, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether it is feasible to use the LifeScience Technologies application (LST app) in patients undergoing radical cystectomy with the eventual goal to reduce complications and readmissions to the hospital after surgery.
Interventions
- OTHER LifeScience Technologies application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02942121
The ClinicalTrials.gov registry entry for NCT02942121 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LifeScience Technologies application is the first listed.
NCT02942121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02942121 about?
NCT02942121 is a clinical study titled "Application-based Perioperative Management of the Radical Cystectomy Patient". The purpose of this study is to learn whether it is feasible to use the LifeScience Technologies application (LST app) in patients undergoing radical cystectomy with the eventual goal to reduce complications and readmissions to the hospital after surgery.
What is the current status of trial NCT02942121?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-09. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02942121?
The interventions under investigation include: LifeScience Technologies application (OTHER).
Who is sponsoring clinical trial NCT02942121?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.